GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $9,190,000 | +18.2% | 257,500 | +24.6% | 1.86% | +21.1% |
| Q3 2020 | $7,778,000 | -19.1% | 206,638 | +0.9% | 1.54% | -32.8% |
| Q4 2019 | $9,619,000 | -36.7% | 204,705 | -46.1% | 2.29% | -37.4% |
| Q2 2019 | $15,188,000 | +38.7% | 379,500 | +44.8% | 3.66% | +23.9% |
| Q1 2019 | $10,949,000 | -25.1% | 262,000 | -28.0% | 2.96% | -41.1% |
| Q3 2018 | $14,620,000 | +26.5% | 363,960 | +11.7% | 5.02% | -23.0% |
| Q4 2017 | $11,557,000 | +4.8% | 325,823 | +19.9% | 6.52% | +13.9% |
| Q3 2017 | $11,031,000 | +126.2% | 271,694 | +140.2% | 5.72% | +146.9% |
| Q2 2017 | $4,877,000 | -55.8% | 113,113 | -56.7% | 2.32% | -62.4% |
| Q1 2017 | $11,025,000 | -18.4% | 261,513 | -25.5% | 6.17% | -21.8% |
| Q4 2016 | $13,510,000 | +6.4% | 350,811 | +15.0% | 7.88% | +25.6% |
| Q2 2015 | $12,703,000 | +41.3% | 305,000 | +45.0% | 6.28% | -11.1% |
| Q4 2014 | $8,991,000 | – | 210,371 | – | 7.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |